collection
MENU ▼
Read by QxMD icon Read
search

Surgical Oncology

shared collection
13 papers 1000+ followers Important papers in Surgical Oncology
By Daniel Tuvin Surgical Oncology fellow at Mount Sinai Hospital
https://www.readbyqxmd.com/read/27770344/when-and-when-not-to-perform-a-right-colon-resection-with-mucinous-appendiceal-neoplasms
#1
Paul H Sugarbaker
BACKGROUND: Mucinous appendiceal neoplasms (MAN) with peritoneal dissemination is treated as a standard of care using cytoreductive surgery and hyperthermic perioperative chemotherapy. The extent of the resection of peritoneal surfaces and visceral structures is generally well defined. Exception to this consensus regarding structures to be removed are the right colon and adjacent ileocolic lymph nodes. METHODS: From a prospectively maintained database, all patients with a histologic diagnosis of peritoneal mucinous carcinoma (PMCA) who underwent complete cytoreductive surgery were assessed for the presence versus absence of adenocarcinoma in lymph nodes within the appendiceal mesentery and/or in the lymph nodes of the ileocolic group...
October 21, 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/27664260/gastric-cancer-esmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up
#2
E C Smyth, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold
No abstract text is available yet for this article.
September 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/27380959/esmo-consensus-guidelines-for-the-management-of-patients-with-metastatic-colorectal-cancer
#3
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky, F Ciardiello, A D'Hoore, E Diaz-Rubio, J-Y Douillard, M Ducreux, A Falcone, A Grothey, T Gruenberger, K Haustermans, V Heinemann, P Hoff, C-H Köhne, R Labianca, P Laurent-Puig, B Ma, T Maughan, K Muro, N Normanno, P Österlund, W J G Oyen, D Papamichael, G Pentheroudakis, P Pfeiffer, T J Price, C Punt, J Ricke, A Roth, R Salazar, W Scheithauer, H J Schmoll, J Tabernero, J Taïeb, S Tejpar, H Wasan, T Yoshino, A Zaanan, D Arnold
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers...
August 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/9849736/perioperative-outcomes-of-major-hepatic-resections-under-low-central-venous-pressure-anesthesia-blood-loss-blood-transfusion-and-the-risk-of-postoperative-renal-dysfunction
#4
J A Melendez, V Arslan, M E Fischer, D Wuest, W R Jarnagin, Y Fong, L H Blumgart
BACKGROUND: We have previously demonstrated that maintenance of a low central venous pressure (LCVP) combined with extrahepatic control of venous outflow reduced the overall blood loss during major hepatic resections. This study examined the overall outcomes and, in particular, renal morbidity associated with a large series of consecutive major liver resections performed with this approach. In addition, the rationale for the anesthetic management to maintain LCVP was carefully reviewed...
December 1998: Journal of the American College of Surgeons
https://www.readbyqxmd.com/read/27156933/gastric-cancer
#5
REVIEW
Eric Van Cutsem, Xavier Sagaert, Baki Topal, Karin Haustermans, Hans Prenen
Gastric cancer is one of the leading causes of cancer-related death worldwide. Many patients have inoperable disease at diagnosis or have recurrent disease after resection with curative intent. Gastric cancer is separated anatomically into true gastric adenocarcinomas and gastro-oesophageal-junction adenocarcinomas, and histologically into diffuse and intestinal types. Gastric cancer should be treated by teams of experts from different disciplines. Surgery is the only curative treatment. For locally advanced disease, adjuvant or neoadjuvant therapy is usually implemented in combination with surgery...
November 26, 2016: Lancet
https://www.readbyqxmd.com/read/26768036/sentinel-lymph-nodes-for-breast-carcinoma-an-update-on-current-practice
#6
REVIEW
Aoife Maguire, Edi Brogi
Sentinel lymph node (SLN) biopsy has been established as the standard of care for axillary staging in patients with invasive breast carcinoma and clinically negative lymph nodes (cN0). Historically, all patients with a positive SLN underwent axillary lymph node dissection (ALND). The ACOSOG Z0011 trial showed that women with T1-T2 disease and cN0 who undergo breast-conserving surgery and whole-breast radiotherapy can safely avoid ALND. The main goal of SLN examination should be to detect all macrometastases (>2 mm)...
January 2016: Histopathology
https://www.readbyqxmd.com/read/26314780/cancer-of-the-pancreas-esmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up
#7
M Ducreux, A Sa Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, T Seufferlein, K Haustermans, J L Van Laethem, T Conroy, D Arnold
No abstract text is available yet for this article.
September 2015: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/26690820/acute-resection-versus-bridge-to-surgery-with-diverting-colostomy-for-patients-with-acute-malignant-left-sided-colonic-obstruction-systematic-review-and-meta-analysis
#8
REVIEW
Femke J Amelung, Charlotte L J Mulder, Paul M Verheijen, Werner A Draaisma, Peter D Siersema, Esther C J Consten
BACKGROUND: Currently, no consensus exists on the best treatment strategy for acute malignant left-sided colonic obstruction. This systematic review and meta-analysis aims to compare the outcomes following the two surgical treatment options; primary resection versus colostomy creation as bridge to surgery. METHODS: This systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to minimize risk of bias...
December 2015: Surgical Oncology
https://www.readbyqxmd.com/read/26661409/outcomes-of-a-clinical-pathway-for-borderline-resectable-pancreatic-cancer
#9
Omar M Rashid, Jose M Pimiento, Andrew W Gamenthaler, Phuong Nguyen, Tin T Ha, Tai Hutchinson, Gregory Springett, Sarah Hoffe, Ravi Shridhar, Pamela J Hodul, Brad L Johnson, Karl Illig, Paul A Armstrong, Barbara A Centeno, William J Fulp, Dung-Tsa Chen, Mokenge P Malafa
BACKGROUND: Without prospective data establishing a consensus multimodality approach to borderline resectable pancreatic adenocarcinoma, institutional treatment regimens vary. This study investigated the outcomes of the clinical pathway at the author's institution, which consists of neoadjuvant gemcitabine, docetaxel, capecitabine, and stereotactic radiotherapy followed by surgery. METHODS: The study reviewed all cases that met the National Comprehensive Cancer Network (NCCN) diagnostic criteria for borderline resectable pancreatic adenocarcinoma from 1 January 2006, to 31 December 2013...
April 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/26631387/decision-making-around-optimal-management-of-liver-limited-metastatic-colorectal-cancer
#10
EDITORIAL
Robert P Jones, Graeme J Poston
No abstract text is available yet for this article.
February 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/23856911/recent-progress-in-pancreatic-cancer
#11
REVIEW
Christopher L Wolfgang, Joseph M Herman, Daniel A Laheru, Alison P Klein, Michael A Erdek, Elliot K Fishman, Ralph H Hruban
Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer...
September 2013: CA: a Cancer Journal for Clinicians
https://www.readbyqxmd.com/read/24493089/risk-of-desmoid-tumours-after-open-and-laparoscopic-colectomy-in-patients-with-familial-adenomatous-polyposis
#12
COMPARATIVE STUDY
M Vitellaro, P Sala, S Signoroni, P Radice, S Fortuzzi, E M Civelli, G Ballardini, D A Kleiman, K P Morrissey, L Bertario
BACKGROUND: Desmoid tumour (DT) is a main cause of death after prophylactic colectomy in patients with familial adenomatous polyposis (FAP). The purpose of this study was to evaluate the impact of prophylactic laparoscopic colectomy on the risk of developing DT in patients with FAP. METHODS: The database of a single institution was reviewed. Patients with classical FAP with defined genotype who underwent either open or laparoscopic colectomy between 1947 and 2011 were included in the study...
April 2014: British Journal of Surgery
https://www.readbyqxmd.com/read/24449318/microrna-biomarkers-in-whole-blood-for-detection-of-pancreatic-cancer
#13
Nicolai A Schultz, Christian Dehlendorff, Benny V Jensen, Jon K Bjerregaard, Kaspar R Nielsen, Stig E Bojesen, Dan Calatayud, Svend E Nielsen, Mette Yilmaz, Niels Henrik Holländer, Klaus K Andersen, Julia S Johansen
IMPORTANCE: Biomarkers for the early diagnosis of patients with pancreatic cancer are needed to improve prognosis. OBJECTIVES: To describe differences in microRNA expression in whole blood between patients with pancreatic cancer, chronic pancreatitis, and healthy participants and to identify panels of microRNAs for use in diagnosis of pancreatic cancer compared with the cancer antigen 19-9 (CA19-9). DESIGN, SETTING, AND PARTICIPANTS: A case-control study that included 409 patients with pancreatic cancer and 25 with chronic pancreatitis who had been included prospectively in the Danish BIOPAC (Biomarkers in Patients with Pancreatic Cancer) study (July 2008-October 2012) plus 312 blood donors as healthy participants...
January 22, 2014: JAMA: the Journal of the American Medical Association
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"